Brief: Enlivex Reports Positive Allocetra Trial Results In Covid-19 Patients

Enlivex

01/10/2020 11:34

Oct 1 (Reuters) - Enlivex Therapeutics Ltd  ENLV.TA :
    * ENLIVEX REPORTS POSITIVE ALLOCETRA TRIAL RESULTS IN
COVID-19
PATIENTS IN SEVERE/CRITICAL CONDITION
    * ENLIVEX THERAPEUTICS LTD - THERE WERE NO REPORTED SEVERE
ADVERSE
EVENTS IN CLINICAL TRIAL
    * ENLIVEX THERAPEUTICS LTD - THERAPY WAS WELL-TOLERATED
    * ENLIVEX THERAPEUTICS LTD - PHASE IIB TRIAL IS EXPECTED TO
COMMENCE IN Q4 OF 2020
    * ENLIVEX - DETERMINED TO SHIFT RECRUITMENT OF ADDITIONAL
PATIENTS
INTO LARGER PHASE II CLINICAL TRIAL OF COVID-19 PATIENTS IN
SEVERE/CRITICAL CONDITION
    * ENLIVEX - INITIAL POSITIVE RESULTS IN SEPSIS PATIENTS
TREATED
WITH ALLOCETRA CONSISTENT WITH THOSE OBSERVED IN COVID-19
PATIENTS IN SEVERE, CRITICAL CONDITION

Source text for Eikon:  ID:nGNX1mW30S 
Further company coverage:  ENLV.TA 

 ((Reuters.Briefs@thomsonreuters.com;))